The First People's Hospital of Jining City
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Liu, Ning bo
NCT04714190: A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression

Recruiting
3
351
RoW
RC48-ADC, Recombinant Humanized anti-HER2 Monoclonal Antibody-MMAE Conjugate For Injection, Paclitaxel injection, Taxol, Irinotecan Hydrochloride Injection, CAMPTO, Apatinib Mesylate Tablets, Aitan
RemeGen Co., Ltd.
Gastric Cancer, HER2 Overexpressing Gastric Carcinoma
12/24
06/25
RC48-C006, NCT03500380: A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases

Active, not recruiting
2/3
301
RoW
RC48-ADC, RC48, Lapatinib, Capecitabine
RemeGen Co., Ltd.
Breast Neoplasms, Breast Diseases, Capecitabine, HER2-positive Breast Cancer, HER2 Positive Breast Carcinoma, HER2-positive Advanced Breast With Liver Metastases
07/24
12/24
NCT05370898: The Study of Chinese Medicine for the Treatment of Primary Osteoporosis

Not yet recruiting
N/A
120
RoW
Caltrate D, Chinese medicine prescription, Placebo
Wangjing Hospital, China Academy of Chinese Medical Sciences
Primary Osteoporosis
12/22
05/23
sun, shuyin
NCT04728516: The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients

Not yet recruiting
4
2600
RoW
Vonoprazan-based dual eradication therapy for two weeks, amoxicillin, Pantoprazole
Qilu Hospital of Shandong University
Acute Coronary Syndrome, Helicobacter Pylori Infection
01/23
06/23

Download Options